A substance causing prolonged pressor effects in the rat has been demonstrated in crude protein-free extracts of hypertensive arterial blood (1). This material formed picrates which upon hydrolysis were further purified. Preliminary experiments indicated that a majority of the extracts of arterial blood taken from human hypertensive patients were pressor, while in only a few samples of blood taken from normotensive patients was such activity demonstrated. The present report is concerned with further demonstration of the presence of this vasoactive material and with the type of case in which it occurs (2-5), based upon experience with about 175 samples of blood. Subsequent reports will deal with methods of purification and analysis of chemical structure. The vasoactive substance was present in appreciable quantities in almost every case of hypertension having a nephrogenic component, was found in smaller amounts in cases of "neurogenlc" and "endocrine" hypertension, and was usually absent in cases of "malignant" hypertension. The finding that the "amine" level in hypertensive blood extracts is usually increased (1) has been confirmed.
(Received for publication, June 14, 1950) A substance causing prolonged pressor effects in the rat has been demonstrated in crude protein-free extracts of hypertensive arterial blood (1) . This material formed picrates which upon hydrolysis were further purified. Preliminary experiments indicated that a majority of the extracts of arterial blood taken from human hypertensive patients were pressor, while in only a few samples of blood taken from normotensive patients was such activity demonstrated. The present report is concerned with further demonstration of the presence of this vasoactive material and with the type of case in which it occurs (2-5), based upon experience with about 175 samples of blood. Subsequent reports will deal with methods of purification and analysis of chemical structure. The vasoactive substance was present in appreciable quantities in almost every case of hypertension having a nephrogenic component, was found in smaller amounts in cases of "neurogenlc" and "endocrine" hypertension, and was usually absent in cases of "malignant" hypertension. The finding that the "amine" level in hypertensive blood extracts is usually increased (1) has been confirmed.
Because the substance differs from other known pressor agents and may represent a new naturally occurring compound of great activity, it has been accorded a name--pherentasin t (¢~po = hold up or bear up;~vra~ = pressure). Until chemical identification has been completed, pherentasin is defined as a substance detected by assay in rats, which induces a prolonged pressor response, contains an amine and a carbonyl group necessary for activity, is nonprotein in nature, and can be procured from the arterial blood of many hypertensive patients at concentrations of 1 to 20 ~ per liter.
PRESSOR SUBSTANCES IN ARTERIAL I-IYPERTENSION. II

Methods
Rat Pressor Assay.--Two methods for assay of pherentasin were employed. The first was similar to that previously reported (1) . Rats weighing 250 to 300 gin. were anesthetized with sodium pentobarbital (4.5 mg. per 100 gin. of body weight) and traeheotomy performed. A 22 gauge needle connected to a Hamilton optical manometer was tied into a femoral artery; a needle was tied into the opposite femoral vein for intravenous injection of materials to be tested. A preliminary survey disclosed that rats made hypertensive by partial constriction of one renal artery were about twice as sensitive to the pressor material as normal rats; therefore they were used in order to conserve material.
Extracts were considered positive for pherentasin when the diastolic pressure of the rat was elevated at least 12 ram. Hg 10 minutes or more after the injection, a figure chosen by comparison of the effects of control extracts of blood. Care was taken to insure that the rat did not become anoxic during the experiment. Many of the cruder extracts contained depressor substances which masked the activity; when the depressor material was removed by chemical purification, a pressor response appeared. The depressor responses did not initiate compensatory rises in blood pressure, for the control extracts of blood uniformly contained more depressor material and were not pressor at any stage of purification.
Rat Mesoappendix Assay.--The second method was that developed by Chambers and Zweifach utilizing the blood vessels of the rat's mesoappendix (6). 2 Fasting rats weighing 100 to 150 gin. were anesthetized with sodium pentobarbital and tracheotomy performed. The abdomen was incised and the mesoappendix placed over a small horseshoe-shaped plastic structure. The vessels were viewed directly through a microscope. Ringer's solution containing 1 per cent gelatin at a constant temperature of 38 ° slowly irrigated the surface of the mesoappendix. Solutions of epinephrine in dilutions of 1:250,000 to 1:20,000,000 (4 to 0.5 -y per ml.) were freshly prepared. To determine the sensitivity of the vessds to the minimal vasoconstrictor dose, application of four drops of each solution of epinephrine in increasing concentrations was repeated until slowing of the blood stream through the met-arterioles and precapillaries for 15 to 30 seconds was observed. Care was taken not to exceed the minimal concentration which caused this reaction. After the level of sensitivity was determined by several topical applications of the same concentration of epinephrine, 0.1 ml. of the unknown solution (in this case an extract of blood) was injected into the vein of the tail. Changes in sensitivity of the vessels were then estimated by the application of solutions of epinephrine in gradually increasing or decreasing concentrations. When the vessels reacted to lower concentrations of epinephrine than during the control period, the unknown was considered to contain vasoexcitor material. When the concentration of epinephrine necessary to cause a vasoconstrictor response was greater than during the control, a vasodepressor material was considered to have been injected intravenously.
Applications of solutions of epinephrine were made at intervals of approximately 5 minutes in order to measure the duration of the change in reactivity. The preparation was retested until the reactivity of the vessels had returned to or near to the control value. A change was considered to be significant when the effect of the intravenous injection of the unknown material lasted at least 15 minutes; usually it lasted 20 to 30 minutes. A response was also considered significant when the concentration of epineprine necessary to produce transient vasoconstriction was either doubled or halved; in many cases changes were of much greater magnitude. In general, the sensitivity of the rat's mesoappendix to topically applied epinephrine was found to be similar to that described by Zweifach (6) , concentrations of 1:1,000,000 to 1:4,000,000 causing slowing of the circulation through met-arterioles; the average conWe are indebted to Drs. Shorr and Zweifach for their aid and advice in setting up this method.
centration necessary was approximately 1:2,000,000. Each extract was tested on at least two rats.
Preparation of Extracts.--Arterial blood was taken directly through an 18 gauge needle and a short piece of rubber tubing into about 3 volumes of cold 95 per cent ethanol. Usually 500 nil. of blood was obtained but in some cases this was impossible. Ethanol was added to a total of 11 volumes. The precipitated protein was removed by filtration; to the clear strawcolored solution was added 1 ml. of concentrated hydrochloric acid for each 200 ml. of original blood. The filtrate was evaporated almost to dryness in an atmosphere of nitrogen under a partial vacuum, care being taken to maintain the temperature below 35°C. The crude extracts were prepared as reported previously (1), placed in a deep freeze and kept in a frozen state until assays were made. The extracts were further purified by the use of anionic and cationic exchange resins (IR-100I-I and IR-4B) and by chloroform extraction; the details of the methods will be reported (7) . The final solution containing the active agent was waterclear, the purest preparations containing approximately 10 to 20 3' of solids per liter of original blood. The amount used for pressor assay was equivalent to 10 cc. of original blood which had been concentrated to 0.5 mi., dissolved in saline solution, and neutralized to pH 7.4 by the addition of sodium bicarbonate. A]though the final extracts may not have been completely pure, 0.1 to 0.2 3" caused prolonged pressor responses in the rat, a range of dosage approximately equivalent to that of arterenol. About 0.01 to 0.02 3" produced vasoexcitor responses in the mesoappendix test.
Classification of Patients.--Patients were classified according to a method previously reported (8, 9) . In brief, an attempt was made to place cases in one of four categories, depending upon the diseases or conditions. For the purposes of the present study, modifications in the classification were introduced.
"Neurogenic hypertension" included those cases exhibiting a fluctuating blood pressure, a positive test to intradermal histamine (10) with the development of the "diencephalic" blush, a low "floor'; after the intravenous injection of tetraethyl ammonium chloride (11), few symptoms, and a rather benign course even though levels of blood pressure might be quite high. These patients showed little evidence of organic renal disease secondary to hypertension and the function of their kidneys was relatively normal. Sleep induced by sodium amytal was accompanied by a pronounced fall of blood pressure. There were 47 cases in this category.
Patients with the "endocrine hypertensive syndrome" were characterized by the presence of obesity of the "central" type (trunk, thighs, upper arms), menstrual irregularities, other disturbances suggestive of endocrine disorders, and the presence of a low concentration of sodium in the sweat (12) . Their blood pressures often became considerably reduced upon restriction of dietary salt (13) . There were 12 patients in this category.
Patients with renal hypertension included two types: first, those suffering from primary organic renal diseases at the onset of hypertension or during its course, which were subsequently "masked;" second, patients believed to be suffering from secondary arteriolar nephrosclerosis. Both types exhibited a relative lack of response to the intravenous injection of tetraethyl ammonium chloride or to sleep induced by sodium amytal. In general, diastolic pressures were "fixed" at relatively high levels; slight to moderate diminution of renal function, as measured by the ability of the kidneys to concentrate urine and by the urea clearance, was present; and a more severe type of disease had developed. Nitrogen retention was not demonstrable in any. There were 35 cases of this type.
Patients with malignant hypertension exhibited a rapid downhill course, had diminished renal function, and hemorrhagic and exudative lesions in the ocular fundi with or without papilledema. When these lesions were present in the ocular fundi without retention of nitrogen, the patients were considered to exhibit early malignant hypertension. There were 17 cases of this nature.
PRESSOR SUBSTANCES IN ARTERIAL ]tYPERTI~NSION, IX
Normotensive subjects were chosen from amongst ward patients who suffered from diseases not considered to be related to arterial hypertension. They furnished the control specimens. In every case their diastolic pressures were below 90 ram. Hg. There were 23 patients in the group. Five samples of venous blood obtained from the blood bank were also tested.
Estimation of Amines.--"Amines" in the crude extracts of blood were measured by the method of Richter (14) ; the intensity of the yellow color developing on the addition of picric acid after extraction from alkaline solution into toluene was considered an estimate of the amine content. The concentration was calculated in terms of isoamylamine, as different amines give different color-concentration curves (7).
RESULTS
Control Specimens:---Of 28 samples tested by rat pressor assay only 1 conmined pressor material; the donor suffered from infectious mononucleosis (Table I ). The mesoappendix test was employed on 19 samples; in only 2 was it positive, one being the patient with infectious mononucleosis, and the other an elderly woman convalescent from pneumonia. None of the 5 samples of venous blood obtained from the blood bank contained vasoactive substances as measured by either method.
Specimens from Patients with Hypertension:--Only 10 of 47 extracts of blood
taken from patients with neurogenic hypertension showed pressor activity in the rat. The mesoappendix test, however, was positive for vasoexcitor substances in 10 of 11 cases (Table II) ; 8 of these extracts were not pressor.
Of 35 samples taken from patients with renal hypertension, 33 gave prolonged pressor responses in the rat. Ten extracts were also tested by the mesoappendix method; all contained vasoexcitor material.
From cases of malignant hypertension only 5 of 17 extracts were pressor in the rat; 2 of the patients yielding them suffered from cardiac insufficiency, and the other 3 were in initial phases of the malignant stage. No activity was exhibited by extracts of the blood of patients with malignant hypertension and uremia; none of the 3 samples tested by the mesoappendix method yielded a positive result.
Three of 12 samples of blood from patients exhibiting the endocrine hypertensive syndrome contained pressor substance. Each of 3 others gave evidence of vasoexcitor substances in the mesoappendix test.
Comparison of Results by the Two Assay Methods:--Correlation of the pressor
response with the reaction of the vessels of the rat's mesoappendix was good in one direction; i.e., a pressor response was always accompanied by a vasoexcitor response. This finding applied to all extracts, fractions, pooled samples, and the more highly purified material. Positive vasoexcitor responses, however, were found not infrequently in the absence of pressor responses, both in single samples (12 cases) and in purified fractions obtained from pools.
Validity of the Assay Method for Pherentasin Utilizing the Rat's Mesoappendix.
--Assays for vasoactive material in hypertensive blood, by the method of Chambers and Zweifach, were more definitive than was the pressor response q-indicates that either pressor or vasoexcitor effects were obtained using the appropriate tests.
--indicates that no pressor or vasoexcitor effects were obtained. 4-indicates that a pressor response was obtained but that it was of short duration (5 minutes or less).
* Rheumatic heart disease.
of the rat. The method was also much more sensitive but it was not specific. It merely discloses the presence of substances affecting the sensitivity of blood vessels to epinephrine. Potentiation of the vasoconstrictor action of epinephrine applied topically was observed after the intravenous injection of ephedrine hydrochloride (0.15 ? to 0.5 rag.), angiotonin (0.05 ml.), and tyramine hydrochloride (0.15 ~, to 0.15 mg.), the effects lasting 15 minutes or longer. Depression of the action of epinephrine was observed after the intravenous injection ) and the acetate and glucoside of desoxycorticosterone (0.5 rag.) caused no change in the response, although the latter was usually pressor for the rat. Over 50 tests with these agents were made and they suificed to indicate that the method, though extremely sensitive, was nonspecific. Hence it was necessary to control most observations on hypertensive extracts with comparable extracts of normotensive blood. Extracts were positive for vasoexcitor material in only 2 of 19 normotensive subjects. Excluding cases in the malignant stages, hypertensive extracts, on the other hand, contained vasoexcitor material in every case tested but one. Pooled samples gave comparable results, those from normotensive subjects containing no vasoexcitor material, whereas combined hypertensive extracts always caused potentiation of the vasoconstrictor action of epinephrine, whether pressor or not.
Tests of purified fractions of the crude extracts of normotensive blood, obtained by the use of ion-exchange resins, indicated that the vasoexcitor substance was not formed during the procedure. All purified fractions of renal hypertensive blood, however, showed activity. The formation of a picrate of the vasoexcitor substance appeared to be a useful method for its separation from depressor substances (7) .
The question naturally arises: Was pherentasin alone detected by the mesoappendix method, or were other vasoexcit'or substances present in certain instances? A definite answer could not be obtained from a large number of experiments performed. Purified pherentasin, which had been recrystailized several times, was both pressor and vasoexcitor. We were unable to separate pressor and vasoexcitor material in any one of numerous fractions and purified samples. Chemical inactivation of the pressor substance by several methods destroyed the vasoexcitor substance (7). The mesoappendix method was capable of detecting one-twentieth of the pressor dose of pherentasin; incomplete fractionation or dilution was the only procedure which retained the vasoexcitor factor while abolishing the pressor response. In two experiments with pooled samples which were not pressor but contained vasoexcitor material, further concentration caused the appearance of pressor effects; probably the material has been too dilute to affect blood pressure in the standard concentrations employed for the pressor test.
Miscellaneous Observations.--Thirty-six samples of blood were taken from 14 patients, and 2 to 5 samples from some of them were assayed months or years apart. The results were consistent in every case, the presence or absence of the pressor material appearing to be constant in the same individual unless the nature of the disease itself had been altered by progression into more severe stages, or unless vigorous therapy had been instituted (Table III) .
During the course of investigation (3 years) the condition of a number of patients altered for the worse or was affected by various procedures. These are informative.
In a 38 year old woman suffering from pyelonephritis and severe hypertension with a strong neurogenic component, 2 samples of blood taken 8 months apart were both positive for pressor substance. A sympathectomy was performed and a sample taken I year later was negative. Two further samples taken a year and 16 months later were negative; in the meantime the pyelonephritis from which she suffered had been controlled by nephrectomy of a diseased kidney. A 38 year old woman with severe hypertension and papiIIedema but with- Ba. A -4-indicates that either pressor or vasoexeitor effects were obtained using the appropriate tests.
A --indicates that no pressor or vasoexcitor effects were obtained. 553 out other evidence of the malignant phase exhibited both pressor and vasoexcitor material in her blood. She was put to bed and given sedatives for several weeks. Her blood pressure dropped to slightly elevated levels, and the pressor but not the vasoexcitor material disappeared. She was then subjected to sympathectomy; another sample contained only vasoexcitor material. A patient with neurogenic hypertension had 3 samples of blood containing no pressor substance; one was vasoexcitor. During 2 years' observation she developed severe hypertension and showed evidence of slight diminution of renal function, with a fixed diastolic pressure. At that time her blood became positive. She was subjected to sympathectomy and after this only vasoexcitor material was found. In 3 other individuals the pressor material was no longer found in the blood after sympathectomy. In these cases the absence of pressor material was not associated with normotensive levels.
No serious attempt was made to determine the relative concentration of vasoactive material in venous and arterial blood. However, 5 samples of normotensive venous blood, both freshly drawn and old, contained no active material. In 2 cases of endocrine hypertension venous samples were negative, but arterial samples were positive. In 2 cases of renal hypertension both venous and arterial samples were positive (Table III) .
In 6 instances right renal venous blood was obtained by intravenous catheter. In 2 normotensive and 1 neurogenic hypertensive case the blood specimen exhibited no pressor activity. In one case of renal hypertension the blood was positive; in another suffering from glomerulonephritis no pressor activity was observed. The injection of epinephrine appeared to cause liberation of vasoexcitor material in 1 instance. In none of these 6 was the renal venous blood positive when blood obtained from other sources was negative.
An attempt was made in 7 instances to cause the liberation of serotonin (15) from normal blood by drawing venous blood into citrate solution, by agitaring citrated blood for 30 minutes, and by using blood 4 to 30 days old from the blood bank. No pressor or vasoexcitor material was detected in the extracts made from such samples.
Amines__In general, crude extracts of hypertensive blood tended to contain more "amines" than did normotensive ones (Fig. 1) , the average value being about twice as great (Table II) , especially in samples from patients with renal hypertension. Arbitrary division of the cases shows that there were "high" values in 18 per cent of extracts from normotensive, 50 per cent of those from neurogenic hypertensive, and 83 per cent of those from renal hypertensive patients.
The height of the amine picrate level was in general poorly correlated with the presence or absence of pressor or vasoexcitor material, save for certain exceptions. The highest normotensive amine picrate level was associated with both a positive pressor response and vasoexcitor material, as were some of the highest amine picrate levels in the neurogenic hypertensive group. Patients with renal hypertension who were almost uniformly positive as regards pressor and vasoexcitor material had in general a more consistently elevated amine picrate level. Purification of the extracts invariably decreased the level while increasing vasoactivity.
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[20 "~. Each bar represents the measurement on blood from a single subject. The solid horizontal lines represent the arithmetical means for each group; the dotted line is an arbitrary division of cases below which all but 3 normotensive values lie. The two bars marked >160 represent extracts which contained so much material as to be cloudy.
DISCUSSION
The results of this study show that pherentasin, a pressor substance eliciting a prolonged response, can be obtained from the blood of cases exhibiting renal hypertension according to the definition here made. Patients with neurogenic hypertension and with the endocrine hypertensive syndrome have yielded less pherentasin. The finding that patients with malignant hypertension usually have little or none is surprising. The malignant stage of hypertension represents a severe change in the character of the disease, involving necrotizing lesions in blood vessels, especially those of the kidney.
We have been unable to find pherentasin in cases of chronic glomerulonephritis with uremia; without uremia it was present only in patients exhibiting predominately hypertensive disease. Hence it does not represent a product of renal retention, and indeed disappears when retention of nitrogen develops. Perhaps other pressor systems, whose effector substances do not survive the procedure of extraction, come into play when the kidney becomes severely damaged. In spite of the fact that relatively large amounts of pherentasin appear in the blood principally in cases of renal hypertension, there is no direct evidence from these data that it is a nephrogenic substance.
Correlation of the presence or absence of pherentasin with the presence of hypertension was more definite in the present study than in the previous one (1) . The relatively crude extracts of blood previously employed contained both pressor and depressor substances. When the depressor material was removed by the process of purification, certain extracts of hypertensive blood which • had been toxic to rats were found to cause pressor and vasoexcitor effects. The presence of pherentasin therefore was masked by depressor substances; the earlier data were probably influenced by the crudeness of the preparations.
More refined techniques and more sensitive methods of assay have shown this vasoactive material in extracts of the blood of almost every patient with hypertension without renal insufficiency. It was not found in cases of chronic glomerulonephritis, malignant hypertension with nitrogen retention, nor in 1 case of pheochromocytoma (I). Of patients with normal blood pressures, I of 2 with infectious mononucleosis and 1 with arteriosclerosis, convalescent from pneumonia, showed vasoactive substance in the blood. There may have been small amounts in certain cases of congestive cardiac failure; too few patients have been studied for conclusions to be drawn. Pherentasin was not found in individuals exhibiting elevated systolic pressures accompanying aortic insu/ficiency, coarctation of aorta, and arteriosclerosis. The large quantities of blood necessary for assay made it impossible to study patients who were seriously fll or to whom the loss of blood would be deleterious. The pressor test in the rat has been found to be a fairly reliable method for the measurement of relatively large quantities of pherentasin under certain conditions. A calculation of the dosage obtained from the purest samples indicated that the method detected approximately 0.2 3'. The extracts of blood containing less than this amount served, in effect, as controls for those that contained more. Variability in the condition of the animals affected their responses to the injections, but when at least 2 injections of an extract were made in each of 2 or more rats in good condition, the results were as consistent as expected in a biological method of assay.
The mesoappendix test detected pherentasin in quantities estimated from dry weights of approximately 0.01 3'. Extracts of normotensive blood treated in exactly the same manner served as controls for extracts of hypertensive blood.
About hal/of these not only contained no vasoexcitor material, but appeared to contain vasodepressor material, a finding not observed in extracts of hypertensive blood The results do not indicate conclusively that pherentasin was the substance measured by this test. When the pressor response was absent and the vasoexcitor response present, it is conceivable that the extract contained other substances which sensitized blood vessels to epinephrine. The results do show, however, that hypertension is usually accompanied by vasoexcitor substances extractable from blood, that these cannot be separated from purified pherentasin, and that both pressor and vasoexcitor materials are inactivated by the same chemical procedures (7) . Because the mesoappendix method is more sensitive in detecting small amounts of vasoactive substances than is the blood pressure of the animal, it is reasonable to assume that pherentasin is being measured by both types of test.
The possibility that the pressor and vasoexcitor material is nicotine seems to have been excluded. Both smokers and non-smokers were equally distributed in the normotensive and hypertensive groups. The pressor response of nicotine is of relatively short duration and it is doubtful that nicotine would be carried through the procedure of extraction. Other exogenous pressor agents can likewise be excluded from consideration.
The procedure for extracting pherentasin was designed to protect amines from destruction by (a) precipitating the proteins in blood and so inactivating their enzymes, (b) preventing oxidation, (c) preventing distillation of volatile substances, (d) inhibiting hydrolysis by maintaining an acid medium and a cold environment, and (e) handling the material at all times with extreme caution. After precipitation of proteins by alcohol and acidification, no drastic chemical or thermal changes were employed. It was obviously impossible to show, however, whether pherentasin was liberated from some parent substance by the procedure of extraction, or existed as such in the original blood. The fact that amines measured by the picrate method survived the extraction is some evidence for the possibility that pherentasin exists under natural conditions. Improved methods for its isolation from smaller quantities of blood may help to settle this question.
An original assumption that the vasoactive material might be highly labile was supported by studies on the stability of the better purified solutions of pherentasin. When extracts were allowed to stand at room temperatures' for several hours or days they became inactive. Too much handling or too frequent thawing also reduced or abolished activity. Instability was especially evident in pooled extracts; it was necessary to exercise extreme caution to preserve the material in a frozen state until immediately before use. Disappearance of the pressor activity was accompanied frequently by the appearance of depressor activity, suggesting that oxidation or hydrolysis of pherentasin produces a substance giving the opposite effect upon blood pressure.
The exact chemical nature of pherentasin is unknown. Chemical inactivation and other studies have indicated that i,t contains a free amine and a carbonyl group necessary for activity (7) . Its pharmacological action differs from that of hypertensin, arterenol, and other known pressor agents. It may possibly represent the effector material of the sustained pressor substance obtained by Shipley, Helmer, and Kohlstaedt (I6), which is probably a protein closely associated with the renin fraction of renal tissue. Its relation to the vasoexcitor material (VEM) of Shorr et al. (17) is also undetermined, although it produces an identical response in the mesoappendix of the rat. VEM has not, however, been purified as yet.
The picrate color measured in the extracts was not indicative of amines of high vasoactivity. The more potent pressor amines, especially those containing phenolic groups, were not measured by the method. Therefore, if significance is to be attached to the amine level in blood, it is only as an estimate of some metabolic fault in amino acid metabolism which may favor the production of other more potent vasoactive amines.
It has not been determined that complete recovery of all the pherentasin the blood could yield was obtained by the methods used. Considering the lability of the substance itself, a considerable amount may have been lost. The dry weight of the most purified active pool obtained showed concentrations of 10 to 20 ~, per liter of original blood. When this concentration was induced in rat's blood by a single injection of 0.2 "r (assuming a blood volume of about 15 ml.) diastolic pressure often rose 20 to 40 mm. Hg for 30 to 60 minutes. To reproduce this response with arterenol (nor-epinephrine) a continuous slow infusionwhich maintained approximately the same concentration in blood would be required; arterenol is rapidly metabolized. Because pherentasin has a pressor activity by weight approximately equal to that of arterenol, but causes a much more prolonged effect, it is doubtful that concentrations much greater than those recovered existed in the original blood of patients. The recovery of pherentasin from human hypertensive blood suggests that it bears a causal or mediating relationship to hypertension. Further studies on its chemical nature are in progress.
S~RY AND CONCLUSIONS
Pherentasin, a highly active pressor substance producing a prolonged effect in the rat, has been obtained in a fairly pure form from the arterial blood of patients with hypertension. Its presence has been demonstrated by two biological methods. It was rarely found in normotensive blood. The blood of patients with renal or nephrogenic hypertension, either primary or secondary, consistently yielded this material. The blood of patients exhibiting neurogenic hypertension and the endocrine hypertensive syndrome had smaller amounts of it. Little or none was found in malignant hypertension. Perhaps pherentasin has a causal relation to the existence of arterial hypertension.
